Post-abortion care with misoprostol - equally effective, safe and accepted when administered by midwives compared to physicians: a randomised controlled equivalence trial in a low-resource setting in Kenya

Marlene Makenzius, Monica Oguttu, Marie Klingberg-Allvin, Kristina Gemzell-Danielsson, Theresa M A Odero, Elisabeth Faxelid, Marlene Makenzius, Monica Oguttu, Marie Klingberg-Allvin, Kristina Gemzell-Danielsson, Theresa M A Odero, Elisabeth Faxelid

Abstract

Objective: To assess the effectiveness of midwives administering misoprostol to women with incomplete abortion seeking post-abortion care (PAC), compared with physicians.

Design: A multicentre randomised controlled equivalence trial. The study was not masked.

Settings: Gynaecological departments in two hospitals in a low-resource setting, Kenya.

Population: Women (n=1094) with incomplete abortion in the first trimester, seeking PAC between 1 June 2013 to 31 May 2016. Participants were randomly assigned to receive treatment from midwives or physicians. 409 and 401 women in the midwife and physician groups, respectively, were included in the per-protocol analysis.

Interventions: 600 µg misoprostol orally, and contraceptive counselling by a physician or midwife.

Main outcome measures: Complete abortion not needing surgical intervention within 7-10 days. The main outcome was analysed on the per-protocol population with a generalised estimating equation model. The predefined equivalence range was -4% to 4%. Secondary outcomes were analysed descriptively.

Results: The proportion of complete abortion was 94.8% (768/810): 390 (95.4%) in the midwife group and 378 (94.3%) in the physician group. The proportion of incomplete abortion was 5.2% (42/810), similarly distributed between midwives and physicians. The model-based risk difference for midwives versus physicians was 1.0% (-4.1 to 2.2). Most women felt safe (97%; 779/799), and 93% (748/801) perceived the treatment as expected/easier than expected. After contraceptive counselling the uptake of a contraceptive method after 7-10 days occurred in 76% (613/810). No serious adverse events were recorded.

Conclusions: Treatment of incomplete abortion with misoprostol provided by midwives is equally effective, safe and accepted by women as when administered by physicians in a low-resource setting. Systematically provided contraceptive counselling in PAC is effective to mitigate unmet need for contraception.

Trial registration number: NCT01865136; Results.

Keywords: Community Gynaecology; Health Policy; Maternal Medicine; Reproductive Medicine.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
Trial profile.

References

    1. Sedgh G, Bearak J, Singh S, et al. . Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends. Lancet 2016;388:258–67. 10.1016/S0140-6736(16)30380-4
    1. Ziraba AK, Izugbara C, Levandowski BA, et al. . Unsafe abortion in Kenya: a cross-sectional study of abortion complication severity and associated factors. BMC Pregnancy Childbirth 2015;15:34 10.1186/s12884-015-0459-6
    1. Safe abortion: technical and policy guidance for health systems, second edition 12. Geneva: World Health Organization, 2012. (accessed 20 Jul 2017).
    1. Singh S. Hospital admissions resulting from unsafe abortion: estimates from 13 developing countries. Lancet 2006;368:1887–92. 10.1016/S0140-6736(06)69778-X
    1. Mayi-Tsonga S, Oksana L, Ndombi I, et al. . Delay in the provision of adequate care to women who died from abortion-related complications in the principal maternity hospital of Gabon. Reprod Health Matters 2009;17:65–70. 10.1016/S0968-8080(09)34465-1
    1. Temmerman M, Khosla R, Laski L, et al. . Women’s health priorities and interventions. BMJ 2015;351:h4147.
    1. Johnston HB, Gallo MF, Benson J. Reducing the costs to health systems of unsafe abortion: a comparison of four strategies. J Fam Plann Reprod Health Care 2007;33:250–7. 10.1783/147118907782101751
    1. Vlassoff M, Walker D, Shearer J, et al. . Estimates of health care system costs of unsafe abortion in Africa and Latin America. Int Perspect Sex Reprod Health 2009;35:114–21. 10.1363/3511409
    1. Prada E, Maddow-Zimet I, Juarez F. The cost of postabortion care and legal abortion in Colombia. Int Perspect Sex Reprod Health 2013;39:114–23. 10.1363/3911413
    1. National Council for Law Reporting. Constitution of Kenya 2010 NCfLRwtAot A-G, ed Nairobi, 2010.
    1. Maina BW, Mutua MM, Sidze EM. Factors associated with repeat induced abortion in Kenya. BMC Public Health 2015;15:1048 10.1186/s12889-015-2400-3
    1. Ochako R, Izugbara C, Okal J, et al. . Contraceptive method choice among women in slum and non-slum communities in Nairobi, Kenya. BMC Womens Health 2016;16:35 10.1186/s12905-016-0314-6
    1. Postabortion Care Consortium. PAC Model. 2015. (accessed 12 Nov 2016).
    1. Gemzell-Danielsson K, Fiala C, Weeks A. Misoprostol: first-line therapy for incomplete miscarriage in the developing world. BJOG 2007;114:1337–9. 10.1111/j.1471-0528.2007.01491.x
    1. Weeks A, Alia G, Blum J, et al. . A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstet Gynecol 2005;106:540–7. 10.1097/01.AOG.0000173799.82687.dc
    1. Blandine T, Ouattara AZ, Coral A, et al. . Sublingual [corrected] misoprostol as first-line care for incomplete abortion in Burkina Faso. Int J Gynaecol Obstet 2012;119:166–9. 10.1016/j.ijgo.2012.05.036
    1. African Population and Health Research Center, Ministry of Health, Kenya, Ipas, and Guttmacher Institute. Incidence and Complications of Unsafe Abortion in Kenya: Key Findings of a National Study Nairobi. Nairobi, Kenya, 2012.
    1. Huber D, Curtis C, Irani L, et al. . Postabortion care: 20 years of strong evidence on emergency treatment, family planning, and other programming components. Glob Health Sci Pract 2016;4:481–94. 10.9745/GHSP-D-16-00052
    1. Fulton BD, Scheffler RM, Sparkes SP, et al. . Health workforce skill mix and task shifting in low income countries: a review of recent evidence. Hum Resour Health 2011;9:1 10.1186/1478-4491-9-1
    1. Osur J, Baird TL, Levandowski BA, et al. . Implementation of misoprostol for postabortion care in Kenya and Uganda: a qualitative evaluation. Glob Health Action 2013;6:19649–11. 10.3402/gha.v6i0.19649
    1. Renner RM, Brahmi D, Kapp N. Who can provide effective and safe termination of pregnancy care? A systematic review*. BJOG 2013;120:23–31. 10.1111/j.1471-0528.2012.03464.x
    1. Cleeve A, Oguttu M, Ganatra B, et al. . Time to act – comprehensive abortion care in east Africa. Lancet Glob Health 2016;4:e601–e602. 10.1016/S2214-109X(16)30136-X
    1. Warriner IK, Wang D, Huong NT, et al. . Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal. Lancet 2011;377:1155–61. 10.1016/S0140-6736(10)62229-5
    1. Olavarrieta CD, Ganatra B, Sorhaindo A, et al. . Nurse versus physician-provision of early medical abortion in Mexico: a randomized controlled non-inferiority trial. Bull World Health Organ 2015;93:249–58. 10.2471/BLT.14.143990
    1. Klingberg-Allvin M, Cleeve A, Atuhairwe S, et al. . Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet 2015;385:2392–8. 10.1016/S0140-6736(14)61935-8
    1. World Health Organization. Optimizing health worker roles to improve access to key maternal and newborn health interventions through task shifting. 2012. (accessed 03 Feb 2017).
    1. Grimes DA, Benson J, Singh S, et al. . Unsafe abortion: the preventable pandemic. Lancet 2006;368:1908–19. 10.1016/S0140-6736(06)69481-6
    1. Shah IH, Åhman E, Ortayli N. Access to safe abortion: progress and challenges since the 1994 International Conference on Population and Development (ICPD). Contraception 2014;90(6 Suppl):S39–S48. 10.1016/j.contraception.2014.04.004
    1. Izugbara CO, Egesa C, Okelo R. ’High profile health facilities can add to your trouble': women, stigma and un/safe abortion in Kenya. Soc Sci Med 2015;141:9–18. 10.1016/j.socscimed.2015.07.019
    1. Piaggio G, Elbourne DR, Pocock SJ, et al. . Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 2012;308:2594–604. 10.1001/jama.2012.87802
    1. Turner KL, Medical abortion training guide. 2nd edn Chapel Hill, NC: Ipas, 2010:29.
    1. WHO. Medical eligibility criteria for contraceptive use.. 2016. (accessed 02 Feb 2017).
    1. Gebreselassie H, Gallo MF, Monyo A, et al. . The magnitude of abortion complications in Kenya. BJOG 2005;112:1229–35. 10.1111/j.1471-0528.2004.00503.x

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다